Targeted Drug Delivery to Stroke via Chemotactic Recruitment of Nanoparticles Coated with Membrane of Engineered Neural Stem Cells
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Cell membrane coating has recently emerged as a promising biomimetic approach to engineering nanoparticles (NPs) for targeted drug delivery. However, simple cell membrane coating may not meet the need for efficient drug delivery to the brain. Here, a novel molecular engineering strategy to modify the surface of NPs with a cell membrane coating for enhanced brain penetration is reported. By using poly(lactic‐co‐glycolic) acid NPs as a model, it is shown that delivery of NPs to the ischemic brain is enhanced through surface coating with the membrane of neural stem cells (NSCs), and the delivery efficiency can be further increased using membrane isolated from NSCs engineered for overexpression of CXCR4. It is found that this enhancement is mediated by the chemotactic interaction of CXCR4 with SDF‐1, which is enriched in the ischemic microenvironment. It is demonstrated that the resulting CXCR4‐overexpressing membrane‐coated NPs, termed CMNPs, significantly augment the efficacy of glyburide, an anti‐edema agent, for stroke treatment. The study suggests a new approach to improving drug delivery to the ischemic brain and establishes a novel formulation of glyburide that can be potentially translated into clinical applications to improve management of human patients with stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Feigin, V. L., Forouzanfar, M. H., Krishnamurthi, R., Mensah, G. A., Connor, M., Bennett, D. A., Moran, A. E., Sacco, R. L., Anderson, L., Truelsen, T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61953-4 · Cited by 3,899
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Chai, Z., Hu, X., Wei, X., Zhan, C., Lu, L., Jiang, K., Su, B., Ruan, H., Ran, D., Fang, R. H., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.027 · Cited by 253
Neural stem cell therapy for subacute and chronic ischemic stroke
Boese, A. C., Le, Q.-S. E., Pham, D., Hamblin, M. H., & Lee, J.-P. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0913-2 · Cited by 205
Exploring new routes for neuroprotective drug development in traumatic brain injury
Janowitz, T., & Menon, D. K. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000330 · Cited by 74
Research works printed but not linked: 33
- 10.1002/ana.20199 · DOI · Paper page
- 10.1161/01.STR.0000144051.32131.09 · DOI · Paper page
- 10.1161/01.STR.22.8.1032 · DOI · Paper page
- 10.1016/S1474-4422(16)30196-X · DOI · Paper page
- 10.1158/1078-0432.CCR-06-2854 · DOI · Paper page
- 10.1166/jnn.2014.9119 · DOI · Paper page
- 10.1016/j.addr.2011.12.006 · DOI · Paper page
- 10.1097/PPO.0b013e318244d8ae · DOI · Paper page
- 10.3390/mi8090262 · DOI · Paper page
- 10.1021/acsnano.8b00553 · DOI · Paper page
- 10.1089/scd.2017.0009 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.105.595918 · DOI
- 10.1182/blood-2003-12-4423 · DOI · Paper page
- 10.1073/pnas.0408258102 · DOI · Paper page
- 10.1093/jnen/63.1.84 · DOI · Paper page
- Rao L., 2018, Adv. Funct. Mater., 28, 34
- 10.2217/14796694.3.1.19 · DOI
- 10.1021/acsnano.8b04787 · DOI
- 10.1073/pnas.1106634108 · DOI · Paper page
- 10.1021/acsami.6b00853 · DOI · Paper page
- 10.1002/adma.201703969 · DOI · Paper page
- 10.1039/c3nr03064d · DOI · Paper page
- 10.1038/nm1390 · DOI · Paper page
- 10.1208/s12248-013-9514-2 · DOI
- 10.1371/journal.pone.0134476 · DOI · Paper page
- 10.4103/1673-5374.224361 · DOI
- 10.1007/s12013-014-0103-5 · DOI
- 10.1097/NEN.0b013e3181fbf6d6 · DOI
- 10.18632/oncotarget.5331 · DOI
- 10.1016/j.biomaterials.2011.09.061 · DOI · Paper page
- 10.1073/pnas.1304504110 · DOI · Paper page
- 10.1016/j.neulet.2015.04.029 · doi:10.1016/j.neulet.2015.04.029
- 10.1016/j.nano.2016.03.005 · DOI · Paper page
Cited by
Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications
Liu, Y., Luo, J., Chen, X., Liu, W., & Chen, T. (2019) · Nano-Micro Letters · doi:10.1007/s40820-019-0330-9 · Cited by 408
Han, L., & Jiang, C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.023 · Cited by 358
Liang, Y., Iqbal, Z., Lu, J., Wang, J., Zhang, H., Chen, X., Duan, L., & Xia, J. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2022.10.008 · Cited by 162
Li, J., Wei, Y., Zhang, C., Bi, R., Qiu, Y., Li, Y., & Hu, B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020621 · Cited by 85
Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy
Fan, L., Wei, A., Gao, Z., & Mu, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114451 · Cited by 57
Metadata
- Authors
- Ma, J., Zhang, S., Liu, J., Liu, F., Du, F., Li, M., Chen, A. T., Bao, Y., Suh, H. W., Avery, J., Deng, G., Zhou, Y., Wu, P., Sheth, K., Wang, H., & Zhou, J.
- Venue
- Small
- Publisher
- Wiley
- Published
- 2019-07-10
- Volume
- 15
- Issue
- 35
- Pages
- e1902011-e1902011
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W2960726587
- Cited by
- 140
- References
- 5
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- Funders
- National Science Foundation (NS095817)
- American Heart Association (18TPA34170180, 19CSLOI34770004)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.